Ropes & Gray advised Kailera Therapeutics, Inc. on the transaction. Kailera Therapeutics, Inc. (“Kailera”) announced raising $400 million in Series A financing. Kailera announced its launch...
Kailera Therapeutics’ $400 Million Series A Financing
Serán Bioscience’s $200 Million Growth Transaction
Ropes & Gray represented Bain Capital Life Sciences in the transaction. Serán Bioscience (“Serán”), a leading contract development and manufacturing organization (CDMO), announced a strategic growth...